Skip to content
Screener

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Pfizer logo
PfizerPFE
15.7%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
35%
Incyte logo
IncyteINCY
27.7%+8.7pp
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
121.5%+103pp
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
16.8%+5.1pp

Other financials

Income statement

See full
Revenue$44.7M+259%
Gross profit$41.7M+288%
Operating income-$110.6M+13.0%
Net income-$100.7M+10.1%
EPS (diluted)-$1.69+12.4%

Balance sheet

See full
Cash & equivalents$99.6M+23.2%
Total debt$31.2M-36.1%
Total equity$1.0B-25.1%
Total assets$1.1B-24.7%

Cash flow

See full
Operating cash flow-$57.3M+25.7%
CapEx$1.2M+38.5%
Free cash flow-$58.5M+25.0%

Valuation

See full
Market cap$1.91B-13.0%
Enterprise value$1.84B-14.8%
P/S19.4×-34.2×

Profitability

See full
Gross margin92%+3.8pp
Operating margin-466.8%-173pp
FCF margin-371.4%-143pp

Returns & leverage

See full
Return on equity-34.3%
Debt / equity0.0×
Current ratio10.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 9:56 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001439222-26-000118

FAQ

What is Agios Pharmaceuticals's net margin?
Agios Pharmaceuticals (AGIO) reported net margin of -418.2% in Q2 2026.
What is the long-term trend for Agios Pharmaceuticals's net margin?
Over 2 years (2020 to 2025), Agios Pharmaceuticals's net margin has grown at a 117.8% compound annual growth rate (CAGR), from -161.1% to -764%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Agios Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude